TR199903014T2 - 5-HT1F Agonistleri olarak yararli karboksamitler. - Google Patents

5-HT1F Agonistleri olarak yararli karboksamitler.

Info

Publication number
TR199903014T2
TR199903014T2 TR1999/03014T TR9903014T TR199903014T2 TR 199903014 T2 TR199903014 T2 TR 199903014T2 TR 1999/03014 T TR1999/03014 T TR 1999/03014T TR 9903014 T TR9903014 T TR 9903014T TR 199903014 T2 TR199903014 T2 TR 199903014T2
Authority
TR
Turkey
Prior art keywords
carboxamides
carboxamides useful
ht1f agonists
ht1f
agonists
Prior art date
Application number
TR1999/03014T
Other languages
English (en)
Inventor
Edward Flaugh Michael
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of TR199903014T2 publication Critical patent/TR199903014T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/94—[b, c]- or [b, d]-condensed containing carbocyclic rings other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

Formül(I). Bu bulus R1, R2, R3 ve n tarifnamede açiklandigi gibi olmak üzere yeni Formül (I) 2-amino-1,2,3,4-tetrahidro-9H-karbazol-6-karboksamitler ve 3-amino-10H-siklohepta[7,6-b]indol-7-karboksamitler sunmaktadir.
TR1999/03014T 1997-06-04 1998-06-01 5-HT1F Agonistleri olarak yararli karboksamitler. TR199903014T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4858497P 1997-06-04 1997-06-04

Publications (1)

Publication Number Publication Date
TR199903014T2 true TR199903014T2 (tr) 2000-05-22

Family

ID=21955349

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/03014T TR199903014T2 (tr) 1997-06-04 1998-06-01 5-HT1F Agonistleri olarak yararli karboksamitler.

Country Status (21)

Country Link
EP (1) EP0882726B1 (tr)
JP (1) JP2002502419A (tr)
KR (1) KR20010013409A (tr)
CN (1) CN1259049A (tr)
AT (1) ATE240953T1 (tr)
AU (1) AU729786B2 (tr)
BR (1) BR9810610A (tr)
CA (1) CA2291624A1 (tr)
DE (1) DE69814735T2 (tr)
DK (1) DK0882726T3 (tr)
EA (1) EA001718B1 (tr)
ES (1) ES2199410T3 (tr)
HU (1) HUP0004142A3 (tr)
ID (1) ID23053A (tr)
IL (1) IL133279A0 (tr)
NO (1) NO995963D0 (tr)
NZ (1) NZ501569A (tr)
PL (1) PL337221A1 (tr)
PT (1) PT882726E (tr)
TR (1) TR199903014T2 (tr)
WO (1) WO1998055115A1 (tr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000034266A1 (en) * 1998-12-11 2000-06-15 Eli Lilly And Company Indole derivatives and their use as 5-ht1f agonists
AU3840000A (en) 1999-04-20 2000-11-02 Meiji Seika Kaisha Ltd. Tricyclic compounds
WO2001010381A2 (en) * 1999-08-04 2001-02-15 Icagen, Inc. Methods for treating or preventing pain and anxiety
JP2003506387A (ja) 1999-08-04 2003-02-18 アイカゲン インコーポレイテッド カリウムチャンネルオープナーとしてのベンズアニリド
US6495550B2 (en) 1999-08-04 2002-12-17 Icagen, Inc. Pyridine-substituted benzanilides as potassium ion channel openers
TWI263497B (en) 2002-03-29 2006-10-11 Lilly Co Eli Pyridinoylpiperidines as 5-HT1F agonists
JP2006523692A (ja) 2003-04-18 2006-10-19 イーライ リリー アンド カンパニー ５−ｈｔ１ｆ作用薬としての（ピペリジニルオキシ）フェニル、（ピペリジニルオキシ）ピリジニル、（ピペリジニルスルファニル）フェニル、および（ピペリジニルスルファニル）ピリジニル化合物
UA82711C2 (en) 2003-09-12 2008-05-12 Эли Лилли Энд Компани Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-ht1f agonists
CA2549007A1 (en) * 2003-12-17 2005-07-07 Eli Lilly And Company Substituted (4-aminocyclohexen-1-yl)phenyl and (4-aminocyclohexen-1-yl)pyridinyl compounds as 5-ht1f agonists
KR20080044273A (ko) 2005-08-08 2008-05-20 아스텔라스세이야쿠 가부시키가이샤 아실구아니딘 유도체 또는 그의 염
CN101627013A (zh) * 2007-02-07 2010-01-13 安斯泰来制药有限公司 酰基胍衍生物
KR101444572B1 (ko) * 2010-03-22 2014-09-24 액테리온 파마슈티칼 리미티드 3-(헤테로아릴-아미노)-1,2,3,4-테트라히드로-9ｈ-카르바졸 유도체 및 이의 프로스타글란딘 ｄ2 수용체 조절제로서의 용도
CA2795062A1 (en) 2010-04-02 2011-10-06 Colucid Pharmaceuticals, Inc. Compositions and methods of synthesis of pyridinoylpiperidine 5-ht1f agonists
CA2909117A1 (en) * 2013-04-09 2014-10-16 Cresset Biomolecular Discovery Ltd The treatment of inflammatory disorders
AR119319A1 (es) 2019-07-09 2021-12-09 Lilly Co Eli Procesos e intermediario para la preparación a gran escala de hemisuccinato de 2,4,6-trifluoro-n-[6-(1-metil-piperidina-4-carbonil)-piridin-2-il]-benzamida y preparación de acetato de 2,4,6-trifluoro-n-[6-(1-metil-piperidina-4-carbonil)-piridin-2-il]-benzamida
CN112125836A (zh) * 2020-10-15 2020-12-25 濮阳惠成电子材料股份有限公司 有机电致光电材料中间体n-苯基咔唑-3-羧酸乙酯的合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9226566D0 (en) * 1992-12-21 1993-02-17 Smithkline Beecham Plc Compounds
US5521196A (en) * 1994-10-05 1996-05-28 Eli Lilly And Company 5-HT1F agonists for the treatment of migraine
CN1184425A (zh) * 1995-03-20 1998-06-10 伊莱利利公司 5－取代－3－(1,2,3,6－四氢吡啶－4－基)－和3－(哌啶－4－基)－1h－吲哚:新型5－ht1f激动剂
EP0749962B1 (en) * 1995-06-23 2000-11-02 Eli Lilly And Company 6-substituted-1,2,3,4-tetrahydro-9H-carbazoles and 7-substituted-10H-cyclohepta(7,6-B)indoles

Also Published As

Publication number Publication date
AU7795598A (en) 1998-12-21
NZ501569A (en) 2001-11-30
DE69814735T2 (de) 2004-03-25
DK0882726T3 (da) 2003-09-22
DE69814735D1 (de) 2003-06-26
EA001718B1 (ru) 2001-08-27
HUP0004142A3 (en) 2002-10-28
ID23053A (id) 2000-01-20
JP2002502419A (ja) 2002-01-22
PL337221A1 (en) 2000-08-14
ATE240953T1 (de) 2003-06-15
NO995963L (no) 1999-12-03
EP0882726A1 (en) 1998-12-09
PT882726E (pt) 2003-09-30
CN1259049A (zh) 2000-07-05
ES2199410T3 (es) 2004-02-16
NO995963D0 (no) 1999-12-03
AU729786B2 (en) 2001-02-08
IL133279A0 (en) 2001-04-30
HUP0004142A2 (hu) 2001-05-28
EP0882726B1 (en) 2003-05-21
WO1998055115A1 (en) 1998-12-10
BR9810610A (pt) 2000-09-12
CA2291624A1 (en) 1998-12-10
EA199901113A1 (ru) 2000-08-28
KR20010013409A (ko) 2001-02-26

Similar Documents

Publication Publication Date Title
UY34152A (es) ?oxazolidinonas substituidas y su uso?.
TR199903014T2 (tr) 5-HT1F Agonistleri olarak yararli karboksamitler.
ATE218859T1 (de) Liganden des neuropeptids y
BR9808491A (pt) Compostos calcilìticos
CA2354023A1 (en) Phenylglycine derivatives
BR0215405A (pt) Composições e processos de uso de collajolie
SE9702773D0 (sv) Novel compounds
TR199901282T2 (tr) Heterosiklik olarak ikame edilmis yeni benzamitler.
TR200100426T2 (tr) Nematisit pirazoller
DE69128473D1 (de) An sigma-bindungsstellen wirkende stoffe
TR200000697T2 (tr) İkame edilmiş 1,2,3,4,5,6-Heksahidro-2,6-Metano-3-Benzazosin-10-OL'ler, üretim yöntemleri ve farmasötik preparat olarak kullanımları.
TR200101493T2 (tr) Eletriptan hidrobromid monohidrat
DK1204659T3 (da) Serotonerge benzofuraner
TR200001182T2 (tr) Yeni karbonik asit türevleri, üretimleri ve kullanımları.
DE69725459D1 (de) Substituierte 1,2,3,4-tetrahydro-2-dibenzofuranamine und 2-aminocyclohepta(b)benzofurane
TR199701298T1 (tr) Tetralinler.
FR2764602B1 (fr) Composition cosmetique comprenant un amide et nouveaux amides
DE59100763D1 (de) Elektrode für medizinische Anwendungen.
DE69937603D1 (de) Dihydro-benzo(1,4)oxazine und tetrahydro-quinoxaline
DE69012619T2 (de) Bis(1-Hydrocarbyloxy-2,2,6,6-tetramethylpiperidin-4-yl)-amin-derivate und stabilisierte Zusammensetzungen.
ATE213236T1 (de) Substituierte benzyloxyimino-verbindungen
FI964278A0 (fi) Menetelmä 5,6-dihydroksi-2-amino-1,2,3,4-tetrahydronaftaleenin johdannaisten valmistamiseksi
IT1296403B1 (it) Macchina per l'applicazione di silicone su calze autoreggenti.
SU1690339A1 (ru) N-(3-хлоро-1,4-нафтохинонил-2)-2-d,l-аспарагиновая кислота, проявляющая кардиостимулирующие свойства
GR1001405B (el) Ενώσεις 2-πιπεραζινόνης και η παραγωγή και η χρησιμοποίηση αυτών.